Chemically, oxiracetam is similar to piracetam, though stronger in effect. It is one of the more commonly used smart drugs, and known by a number of names, including CT-848, hydroxypiracetam, ISF-2522, Neuractiv, and Neuromet.
Oxiracetam has had the most widespread use in Italy, where it was developed in 1988 by ICF, an Italian drug company. In the U.S., use has not been approved by the FDA. Smith Kline Beckman Corporation is trying to get the drug approved for treating Alzheimer’s disease.
Some research indicates that the effects of oxiracetam may be greater than those of piracetam in improving elderly subjects ability to remember things. Oxiracetam has been shown to be nontoxic, like other nootropics, as well as safe in dosages that far exceed what the average person takes.
